Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
When planning a moderately hypofractionationed treatment for prostate cancer, do you recommend using a bladder volume dose constraint?
For example V70<10cc? Or do you stick with % of organ volume dose constraints?
Answer from: Radiation Oncologist at Community Practice
We aim for 70 Gy < 10 and 35 Gy < 40 - 50 and try to avoid hot spot in bladder trigone region.
Comments
Radiation Oncologist at CCare
I noticed 70Gy <10cc and the lower V40 constrai...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
We do treat all with hypofractionation.
6198
6199
Sign in or Register to read more
10419
Related Questions
Would you offer salvage radiation for a local recurrence of prostate cancer that was initially treated with SBRT?
For a patient with a rising PSA after prostatectomy with seminal vesicles being negative for disease at surgery, do you ever treat the prostate bed and seminal vesicle bed with different doses in an SIB plan?
How do you decide between internal versus external decompression of malignant obstruction of the ureter (MUO)?
Would you treat someone following FLAME protocol for prostate cancer without fiducials if using daily CBCT?
For a patient post-prostatectomy with a high PSA (>1), a negative MRI pelvis, and a negative PSMA PET scan, do you pursue any other imaging?
How do you incorporate absolute percent pattern 4 (APP4) into your risk stratification, specifically your recommendation for ADT for intermediate prostate cancer?
Do you ever dose escalate radiotherapy to the primary in low volume metastatic prostate cancer?
How do you reconcile discordant PSMA and MRI findings in patients undergoing definitive radiotherapy for prostate cancer?
Given the different rates of testosterone recovery, do you alter the duration of ADT when using Leuprorelin (GnRH Agonist) vs relugolix (GnRH antagonist) in patients with intermediate or high-risk prostate cancer who received definitive radiation?
How do you counsel/advise patients when asked to compare ultrahypofractionated radiotherapy with the TULSA procedure?
I noticed 70Gy <10cc and the lower V40 constrai...
We do treat all with hypofractionation.